Major study launches to track Real-World eczema drug effects in 1500 teens
NCT ID NCT06238765
Summary
This study is creating a large international registry to track the long-term safety and real-world effectiveness of approved eczema medications in teenagers. It will follow about 1500 adolescents, aged 12-15, who have moderate to severe eczema and are starting a new treatment. The goal is to collect detailed information on how well the drugs work, their side effects, and how the disease progresses over time to help doctors, patients, and regulators make better decisions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CorEvitas, LLC
RECRUITINGWaltham, Massachusetts, 02451, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.